Literature DB >> 8060496

Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.

A Liwo1, K D Gibson, H A Scheraga, P W Brandt-Rauf, R Monaco, M R Pincus.   

Abstract

Oncogenic p21 protein, encoded by the ras-oncogene, that causes malignant transformation of normal cells and many human tumors, is almost identical in sequence to its normal protooncogene-encoded counterpart protein, except for the substitution of arbitrary amino acids for the normally occurring amino acids at critical positions such as Gly 12 and Gln 61. Since p21 is normally activated by the binding of GTP in place of GDP, it has been postulated that oncogenic forms must retain bound GTP for prolonged time periods. However, two multiply substituted p21 proteins have been cloned, neither of which binds GDP or GTP. One of these mutant proteins with Val for Gly 10, Arg for Gly 12, and Thr for Ala 59 causes cell transformation, while the other, similar protein with Gly 10, Arg 12, Val for Gly 13 and Thr 59 does not transform cells. To define the critical conformational changes that occur in the p21 protein that cause it to become oncogenic, we have calculated the low energy conformations of the two multiply substituted mutant p21 proteins using a new adaptation of the electrostatically driven Monte Carlo (EDMC) technique, based on the program ECEPP. We have used this method to explore the conformational space available to both proteins and to compute the average structures for both using statistical mechanical averaging. Comparison of the average structures allows us to detect the major differences in conformation between the two proteins. Starting structures for each protein were calculated using the recently deposited x-ray crystal coordinates for the p21 protein, that was energy-refined using ECEPP, and then perturbed using the EDMC method to compute its average structure. The specific amino acid substitutions for both proteins were then generated into the lowest energy structure generated by this procedure, subjected to energy minimization and then to full EDMC perturbations. We find that both mutant proteins exhibit major differences in conformation in specific regions, viz., residues 35-47, 55-78, 81-93, 96-110, 115-126, and 123-134, compared with the EDMC-refined x-ray structure of the wild-type protein. These regions have been found to be the most flexible in the p21 protein bound to GDP from prior molecular dynamics calculations (Dykes et al., 1993). Comparison of the EDMC-average structure of the transforming mutant with that of the nontransforming mutant reveals major structural differences at residues 10-16, 32-40, and 60-68. These structural differences appear to be the ones that are critical in activation of the p21 protein.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8060496     DOI: 10.1007/bf01891982

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  35 in total

1.  Empirical solvation models in the context of conformational energy searches: application to bovine pancreatic trypsin inhibitor.

Authors:  R L Williams; J Vila; G Perrot; H A Scheraga
Journal:  Proteins       Date:  1992-09

2.  ras proteins can induce meiosis in Xenopus oocytes.

Authors:  C Birchmeier; D Broek; M Wigler
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

3.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

4.  On the multiple-minima problem in the conformational analysis of polypeptides. II. An electrostatically driven Monte Carlo method--tests on poly(L-alanine).

Authors:  D R Ripoll; H A Scheraga
Journal:  Biopolymers       Date:  1988-08       Impact factor: 2.505

5.  Prediction of protein conformation on the basis of a search for compact structures: test on avian pancreatic polypeptide.

Authors:  A Liwo; M R Pincus; R J Wawak; S Rackovsky; H A Scheraga
Journal:  Protein Sci       Date:  1993-10       Impact factor: 6.725

6.  Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis.

Authors:  D J Clanton; Y Y Lu; D G Blair; T Y Shih
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

7.  Comparison of the predicted structure for the activated form of the P21 protein with the X-ray crystal structure.

Authors:  J M Chen; G Lee; P W Brandt-Rauf; R B Murphy; S Rackovsky; M R Pincus
Journal:  J Protein Chem       Date:  1990-10

8.  Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.

Authors:  P Chardin; J H Camonis; N W Gale; L van Aelst; J Schlessinger; M H Wigler; D Bar-Sagi
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

9.  All ras proteins are polyisoprenylated but only some are palmitoylated.

Authors:  J F Hancock; A I Magee; J E Childs; C J Marshall
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

10.  The structure of the amino terminal transforming segment of the p21 protein, Tyr4-Thr20 (with Asp12), by two-dimensional NMR.

Authors:  P A Longo; M S Broido; J Chen; H F Kung; M R Pincus
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

View more
  9 in total

1.  Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these domains in ras signaling.

Authors:  Thomas Duncan; James M Chen; Fred K Friedman; Mark Hyde; Lyndon Chie; Matthew R Pincus
Journal:  Protein J       Date:  2004-04       Impact factor: 2.371

2.  Prediction of the three-dimensional structure of the rap-1A protein from its homology to the ras-gene-encoded p21 protein.

Authors:  J M Chen; R Grad; R Monaco; M R Pincus
Journal:  J Protein Chem       Date:  1996-01

3.  Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins.

Authors:  R Monaco; J M Chen; F K Friedman; P Brandt-Rauf; D Chung; M R Pincus
Journal:  J Protein Chem       Date:  1995-11

4.  Computed three-dimensional structures for the ras-binding domain of the raf-p74 protein complexed with ras-p21 and with its suppressor protein, rap-1A.

Authors:  J M Chen; S Manolatos; P W Brandt-Rauf; R B Murphy; R Monaco; M R Pincus
Journal:  J Protein Chem       Date:  1996-08

5.  Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein.

Authors:  R Monaco; J M Chen; D Chung; P Brandt-Rauf; M R Pincus
Journal:  J Protein Chem       Date:  1995-08

6.  Complexes of p21RAS with JUN N-terminal kinase and JUN proteins.

Authors:  V Adler; M R Pincus; P W Brandt-Rauf; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Conformational effects in the p53 protein of mutations induced during chemical carcinogenesis: molecular dynamic and immunologic analyses.

Authors:  P W Brandt-Rauf; J M Chen; M J Marion; S J Smith; J C Luo; W Carney; M R Pincus
Journal:  J Protein Chem       Date:  1996-05

8.  Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.

Authors:  Wilbur B Bowne; Josef Michl; Martin H Bluth; Michael E Zenilman; Matthew R Pincus
Journal:  Cancer Ther       Date:  2007

9.  Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population.

Authors:  Sara Tomei; Sharon Adams; Lorenzo Uccellini; Davide Bedognetti; Valeria De Giorgi; Narnygerel Erdenebileg; Maria Libera Ascierto; Jennifer Reinboth; Qiuzhen Liu; Generoso Bevilacqua; Ena Wang; Chiara Mazzanti; Francesco M Marincola
Journal:  Med Oncol       Date:  2012-05-22       Impact factor: 3.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.